These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19914307)

  • 1. Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice.
    Ishizuka Y; Abe H; Tanoue A; Kannan H; Ishida Y
    Neurosci Res; 2010 Mar; 66(3):233-7. PubMed ID: 19914307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin V1a, but not V1b, receptors within the PVN of lactating rats mediate maternal care and anxiety-related behaviour.
    Bayerl DS; Hönig JN; Bosch OJ
    Behav Brain Res; 2016 May; 305():18-22. PubMed ID: 26909846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central V1b receptor antagonism in lactating rats: impairment of maternal care but not of maternal aggression.
    Bayerl DS; Klampfl SM; Bosch OJ
    J Neuroendocrinol; 2014 Dec; 26(12):918-26. PubMed ID: 25283607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation.
    Nakamura K; Fujiwara Y; Mizutani R; Sanbe A; Miyauchi N; Hiroyama M; Yamauchi J; Yamashita T; Nakamura S; Mori T; Tsujimoto G; Tanoue A
    Endocrinology; 2008 Oct; 149(10):4883-91. PubMed ID: 18583426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of V1b receptors promotes maternal motivation to retrieve pups in the MPOA and impairs pup-directed behavior during maternal defense in the mpBNST of lactating rats.
    Bayerl DS; Kaczmarek V; Jurek B; van den Burg EH; Neumann ID; Gaßner BM; Klampfl SM; Bosch OJ
    Horm Behav; 2016 Mar; 79():18-27. PubMed ID: 26747375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
    Stewart LQ; Roper JA; Young WS; O'Carroll AM; Lolait SJ
    Psychoneuroendocrinology; 2008 May; 33(4):405-15. PubMed ID: 18243568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.
    Tanoue A; Ito S; Honda K; Oshikawa S; Kitagawa Y; Koshimizu TA; Mori T; Tsujimoto G
    J Clin Invest; 2004 Jan; 113(2):302-9. PubMed ID: 14722621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic social defeat on behavioral and neural correlates of sociality: Vasopressin, oxytocin and the vasopressinergic V1b receptor.
    Litvin Y; Murakami G; Pfaff DW
    Physiol Behav; 2011 Jun; 103(3-4):393-403. PubMed ID: 21397619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vasopressin 1b receptor (V1bR) blockade on HPA axis activity in rats exposed to acute heat stress.
    Jasnic N; Djordjevic J; Vujovic P; Lakic I; Djurasevic S; Cvijic G
    J Exp Biol; 2013 Jun; 216(Pt 12):2302-7. PubMed ID: 23580725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic hyperglycemic effects of vasopressin in normal rats: involvement of V
    Taveau C; Chollet C; Bichet DG; Velho G; Guillon G; Corbani M; Roussel R; Bankir L; Melander O; Bouby N
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E127-E135. PubMed ID: 27998960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs.
    Egashira N; Tanoue A; Higashihara F; Fuchigami H; Sano K; Mishima K; Fukue Y; Nagai H; Takano Y; Tsujimoto G; Stemmelin J; Griebel G; Iwasaki K; Ikeda T; Nishimura R; Fujiwara M
    Neuropsychopharmacology; 2005 Nov; 30(11):1996-2005. PubMed ID: 15956991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression.
    Hodgson RA; Higgins GA; Guthrie DH; Lu SX; Pond AJ; Mullins DE; Guzzi MF; Parker EM; Varty GB
    Pharmacol Biochem Behav; 2007 Mar; 86(3):431-40. PubMed ID: 17291571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vasopressin V1b Receptor Blockade on Activity of the Hypothalamic-Pituitary-Adrenal Axis in Old Monkeys with Depression-Like and Anxious Behavior Subjected to Stress or Injected with Vasopressin.
    Goncharova ND; Chigarova OA; Oganyan TE
    Bull Exp Biol Med; 2018 Nov; 166(1):86-91. PubMed ID: 30450521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.
    Zhou Y; Colombo G; Carai MA; Ho A; Gessa GL; Kreek MJ
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1876-83. PubMed ID: 21575018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasopressin V1b receptor antagonist, SSR149415, on anxiety-like behavior and Lewis lung carcinoma metastasis in mice.
    Amikishieva AV; Ilnitskaya SI; Nikolin VP; Popova NA
    Exp Oncol; 2011 Sep; 33(3):126-9. PubMed ID: 21956463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a functional V
    Hus-Citharel A; Bouby N; Corbani M; Mion J; Mendre C; Darusi J; Tomboly C; Trueba M; Serradeil-Le Gal C; Llorens-Cortes C; Guillon G
    Am J Physiol Renal Physiol; 2021 Sep; 321(3):F305-F321. PubMed ID: 34282956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
    Serradeil-Le Gal C; Wagnon J; Tonnerre B; Roux R; Garcia G; Griebel G; Aulombard A
    CNS Drug Rev; 2005; 11(1):53-68. PubMed ID: 15867952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions.
    Egashira N; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    J Pharmacol Sci; 2009 Jan; 109(1):44-9. PubMed ID: 19151541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.